Initial findings show the potential of Lung EpiCheck to detect early-stage lung cancer with high sensitivity.
19/10/2023
PETER J. MAZZONE DANNY FRUMKIN ADAM WASSERSTROM CARL M TAMMEMAGI STEPHEN C LAM MICHAEL GIESKE LUIS HERRERA SATISH KALANJERI ANNA L. MCGUIRE KIMBERLY RIEGER-CHRIST
JOSEPH C SEAMAN NICHOLE T TANNER THOMAS K WADDELL AND GERARD A SILVESTRI
Utility of bladder EpiCheck methylation test for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin
24/06/2022
Mengual L, Ingelmo-Torres M, Carrasco R, Roldan F.L, Garcia M, Alcaraz A, Izquierdo L, Ribal M.J.
Bladder EpiCheck in clinical decision making in the follow up of non muscle invasive bladder cancer
24/06/2022
Lozano Palacio F, Witjes J.A, Leibovitch I
DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical Trial
21/06/2022
Angelo Territo, Andrea Gallioli, Pietro Diana, Romain Boissier, Matteo Fontana, Josep Maria Gaya, Francesco Sanguedolce, Julio Calderón, Alberto Piana, Sofia Fontanet, Ferran Algaba, Joan Palou, and Alberto Breda
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples
21/06/2022
Angelo Territo, Andrea Gallioli, Pietro Diana, Romain Boissier, Matteo Fontana, Josep Maria Gaya, Francesco Sanguedolce, Julio Calderón, Alberto Piana, Sofia Fontanet, Ferran Algaba, Joan Palou, Alberto Breda
STAY UPDATED ON THE LATEST NEWS FROM NUCLEIX!
Subscription Confirmation Required
Go to your email inbox
Go to the inbox of the email
address you just used to sign up.
Open the confirmation email
Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “info@nucleix.com”.
Click the confirmation link
Click on the link inside the <br>email and you’re good to go.